December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows and residents gathered from December 9-10 to discuss best practices in sports and exercise cardiology, for elite and professional athletes during the
December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment of heart diseases, today announces that the positive results from its pilot study have been published in the medical journal EuroIntervention.
EuroIntervention is well regarded globally as the most prestigious European publication focused on interventional cardiology.
December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.
